Calamos Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Calamos Advisors's MDT Position: Q2 2026 in Review
Calamos Advisors reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $14.3M and leaving 425,833 shares worth $33.3M. The position accounts for 0.11% of the portfolio, ranked #187.
Calamos Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $113M in Q2 2019. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Calamos Advisors held 425,833 shares of Medtronic worth $33.3M as of Q2 2026.
- Calamos Advisors sold 177,132 Medtronic shares in Q2 2026, an estimated $14.3M.
- Medtronic made up 0.11% of Calamos Advisors's portfolio in Q2 2026, its #187 holding.
- Calamos Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Calamos Advisors's Medtronic position peaked at $113M in Q2 2019.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.